- Home
- MGPI vs TYRA Comparison
MGPI vs TYRA Comparison
Compare MGPI & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGPI
- TYRA
- Stock Information
- Founded
- MGPI 1941
- TYRA 2018
- Country
- MGPI United States
- TYRA United States
- Employees
- MGPI N/A
- TYRA N/A
- Industry
- MGPI Beverages (Production/Distribution)
- TYRA Biotechnology: Pharmaceutical Preparations
- Sector
- MGPI Consumer Staples
- TYRA Health Care
- Exchange
- MGPI Nasdaq
- TYRA Nasdaq
- Market Cap
- MGPI 610.9M
- TYRA 571.9M
- IPO Year
- MGPI 1988
- TYRA 2021
- Fundamental
- Price
- MGPI $28.02
- TYRA $12.32
- Analyst Decision
- MGPI Strong Buy
- TYRA Strong Buy
- Analyst Count
- MGPI 5
- TYRA 8
- Target Price
- MGPI $45.40
- TYRA $31.00
- AVG Volume (30 Days)
- MGPI 172.6K
- TYRA 235.9K
- Earning Date
- MGPI 10-30-2025
- TYRA 11-06-2025
- Dividend Yield
- MGPI 1.69%
- TYRA N/A
- EPS Growth
- MGPI N/A
- TYRA N/A
- EPS
- MGPI N/A
- TYRA N/A
- Revenue
- MGPI $609,404,000.00
- TYRA N/A
- Revenue This Year
- MGPI N/A
- TYRA N/A
- Revenue Next Year
- MGPI N/A
- TYRA N/A
- P/E Ratio
- MGPI N/A
- TYRA N/A
- Revenue Growth
- MGPI N/A
- TYRA N/A
- 52 Week Low
- MGPI $25.12
- TYRA $6.42
- 52 Week High
- MGPI $86.60
- TYRA $29.60
- Technical
- Relative Strength Index (RSI)
- MGPI 43.29
- TYRA 56.45
- Support Level
- MGPI $27.50
- TYRA $11.70
- Resistance Level
- MGPI $28.45
- TYRA $12.55
- Average True Range (ATR)
- MGPI 0.86
- TYRA 0.68
- MACD
- MGPI -0.10
- TYRA -0.04
- Stochastic Oscillator
- MGPI 19.92
- TYRA 38.84
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.